Skip to main content
. 2024 Feb 15;73(6):124–130. doi: 10.15585/mmwr.mm7306a2

FIGURE 2.

This figure consists of four line graphs illustrating the percentage of 139,740 drug overdose deaths with evidence of selected routes of drug use, by U.S. Census Bureau region and 6-month period of death, during January 2020–December 2022, based on data from the State Unintentional Drug Overdose Reporting System.

Percentage of drug overdose deaths with evidence of selected routes of drug use,* by U.S. Census Bureau region and 6-month period of death (N = 139,740) — State Unintentional Drug Overdose Reporting System, 28 jurisdictions,§ January 2020–December 2022

* Percentages with evidence of other routes (i.e., buccal, sublingual, suppository, or transdermal) are not presented because of small sample sizes (Panel A [Northeast]: 136, 0.4%; Panel B [Midwest]: 121, 0.4%; Panel C [South]: 223, 0.5%; and Panel D [West]: 103, 0.5%); decedents with drug use via these routes are included in the denominators. In addition, percentages of decedents with no information on route are not shown (Panel A: 22,541, 58.4%; Panel B: 15,381, 50.3%; Panel C: 22,571, 47.3%; and Panel D: 7,767, 34.0%); these decedents are also included in the denominators.

Analysis included some, but not all, of the jurisdictions in each U.S. Census Bureau region. Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Kansas, Minnesota, Nebraska, and Ohio; South: Delaware, District of Columbia, Georgia, Kentucky, Maryland, North Carolina, Oklahoma, Virginia, and West Virginia; West: Alaska, Arizona, Colorado, Oregon, Utah, and Washington.

§ Jurisdictions were included if medical examiner or coroner reports and toxicology reports were available for ≥75% of deaths during January 2020–December 2022. Analysis was restricted to deaths with an available medical examiner or coroner report (139,740; 95.8% of all deaths).